PDF-OPPORTUNITIES TO INCREASE SCREENING AND TREATMENT OF OPIOID USE DISORD

ri ze massachusetts AUTHORS Caroline DavidsonChetna Bansal Shannon Hartley PAGE 2 OPPORTUNITIES TO INCREASE SCREENING TREATMENT OF OUD AMONG HEALTHCARE PROFESSIONALS 2019 SHATTERPROOF PAGE 2 OP. Adam . Bisaga. M.D.. Professor of Psychiatry. Columbia University Medical Center. Workshop Outline. Naltrexone-assisted treatment of OUD. Section 1: . Introduction to antagonist-based treatment of OUD . John e lopes . j. r. .. , . dhs. c. , pa-c. A. ssociate Professor, . Physician Assistant Program. Central Michigan University. and . Project Director. Medication-assisted Treatment Waiver Training Initiative. IN ARMS September 26, 2016. Prepared by. Leslie . Hulvershorn. , MD. Medical Director,. . Division of Mental Health and . Addiction, FSSA. Leslie.Hulvershorn@fssa.IN.gov. Presented by. Dennis Ailes, MA. Welcome. Thank you for joining us for our 1. st. AIM Opioid Webinar. Housekeeping:. Session is being recorded. Session will be posted under the opioid section of the AIM website: . https://safehealthcareforeverywoman.org/national-collaborative-on-maternal-oud/. Opioid . Use . Disorder: . The AIM Bundle. Ronald E Iverson, Jr., MD, MPH. Vice-Chair, Obstetrics, Boston Medical Center. Director, Quality Improvement, OBGYN, Boston Medical Center. Assistant Professor, Boston . Elizabeth Salisbury-Afshar, MD, MPH. Bruce Trigg, MD. Karen Hochman, MD, MPH. Nov 4, 2017. No financial disclosures. The Opioid Crisis in the US: where we are and how we got here. Access to effective pain and opioid use disorder treatment. Medication Assisted Treatment For Opioid Use Disorders Shannon Allen, MD Jade Wellness Center July 19, 2018 Rates of Relapse in Opioid Use Disorders are High Benefits of Medication Assisted Treatments and . M. edication . Assisted Treatment . and . Team . Training in . Rural . Colorado. Behavioral Health Provider Training. Module 3: . Pharmacology of Buprenorphine and Other Drugs. Copyright 2018 Regents of the University of Colorado.  All Rights Reserved. William J. Lorman, JD, PhD, MSN, PMHNP-BC, CARN-AP. V. P. & Chief Clinical Officer, Livengrin Foundation, Inc.. Ass’t. Clinical Professor, Doctoral Nursing Dept., . Drexel University. wlorman@livengrin.org. Iowa Department of Public Health. Protecting and Improving the Health of . Iowans. Introductions. Iowa Department of Public Health. Division of Behavioral Health – Single State Authority on Substance Use Disorders. A. gonist Treatment . f. or . R. acial and Ethnic Minorities. Jawad M. Husain, MD . 1,2. , Devin Cromartie MD, MPH . 3,4. , Emma . Fitzelle. -Jones, MPH . 5. , . Annelise . Brochier. , MPH . 6. ,. . Farinaz . Khan, . Paul . Romo, MD. Disclosure. None. Outline. Opioids and the Neuroendocrine system. Misuse and Addiction. Treatment . Special Populations- forensics. Objective. By the end of this didactic, you will be able to:. Medication for Addiction Treatment. (MAT). The Faith & Spirituality Integrated SBIRT Network. Navigating the Training. Welcome! These health professionals will guide you through your MAT training.* . Community Justice & Safety Symposium. March 3, 2020. Mae Katt, Nurse Practitioner. Outline. Topic: Opioid Addiction. Mae Katt, NP. Dr Claudette Chase. Edna . Quequish. Swanson . Kenequanash. . Questions & Discussion.